. . . . . . . . . . . . . . . . . . . . . "a(CHEBI:erlotinib) -| (p(HGNC:EGF) -> p(HGNC:EGFR,pmod(P,Y,1086)))" . "p(HGNC:EGF) -> p(HGNC:EGFR,pmod(P,Y,1086))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "H322 cells express wild-type EGFR and have no EGFR gene amplification. EGF led to the expected EGFR activation and later to increased levels of EphA2 protein (Fig. 5); both were significantly decreased by the use of the EGFR inhibitor erlotinib." . . "Selventa" . . . . "2014-07-03T14:33:34.865+02:00"^^ . . .